Press Releases

2010 Press Releases

Listed below are all of the QLT press releases available for the year you have selected.

July 27	QLT Announces Second Quarter Results for 2010	PDF version
June 28	QLT Added to the Russell Global Index	PDF version
June 22	QLT Announces Final Results From Its RADICAL Study Evaluating Verteporfin PDT (Visudyne®) Combination Therapy in Exudative AMD	PDF version
June 15	12-Month Results from DENALI Study Evaluating Verteporfin PDT (Visudyne®) Combination Therapy	PDF version
May 21	QLT Announces Toronto Stock Exchange Approval of Increased Share Repurchase Program	PDF version
May 20	QLT Announces Its Intention to Increase Share Repurchase Program	PDF version
May 6	QLT Announces First Quarter Results for 2010	PDF version
April 20	QLT Announces Positive Interim Results From Phase Ib Study of its Oral Synthetic Retinoid Compound in Leber Congenital Amaurosis	PDF version
April 12	QLT Names Dipak Panigrahi, M.D., Chief Medical Officer	PDF version
March 10	QLT Announces Fourth Quarter and Year End 2009 Results	PDF version
March 10	QLT Announces Phase II Clinical Trial Results and Development Plans for the Punctal Plug Delivery System	PDF version
February 22	QLT Names Joseph L. Turner to the Board of Directors	PDF version

Vancouver Web Design by Graphically Speaking